Michigan CAADC Elite
Test Bank & Study
Guide
PART 0: THE TABLE OF CONTENTS
Section Cognitive Tier Subject Focus Page/Section
Reference
PART I: THE System Initialization Critical Axioms & Exam Section 1.0
PREVIEW Architecture
PART II: THE ELITE Core Assessment Comprehensive Section 2.0
TEST BANK Gauntlet Subject Mastery
- Tier 1 (Questions Foundational Syntax & Definitions, MCBAP Section 2.1
1–10) Application Ethics, ASAM 4th Ed
Baseline
- Tier 2 (Questions Complex Application & MDHHS-5515, 42 CFR Section 2.2
11–20) Simulation Part 2 Updates, Minor
Consent
- Tier 3 (Questions Grandmaster Synthesis Duty to Warn vs Section 2.3
21–30) Federal Law,
Co-occurring Triage
PART I: THE PREVIEW
Mastering this clinical test bank translates directly to elite, unimpeachable clinical competence
within Michigan's highly regulated behavioral health infrastructure. By internalizing these
multidimensional scenarios, you will bypass novice pitfalls, ensuring your diagnostic
formulations and legal compliance meet the absolute highest standards of the Michigan
Certification Board for Addiction Professionals (MCBAP).
Critical Axioms (The Hard Deck):
● The Federal Supremacy Rule (42 CFR Part 2 vs. Duty to Warn): State-mandated Duty
to Warn (MCL 330.1946) NEVER supersedes federal SUD confidentiality (42 CFR Part 2).
You must secure a specific court order, make an anonymous report, or report without
identifying the patient as receiving SUD treatment.
● The ASAM 4th Edition Paradigm Shift: Dimension 1 now explicitly mandates the
evaluation of Addiction Medications, forcing clinicians to view Medication for Addiction
Treatment (MAT) as a frontline biological intervention. Dimension 6 Person-Centered
Considerations now absorbs readiness to change while addressing Social Determinants
of Health (SDOH).
● Michigan Minor Consent Laws: A minor in Michigan possesses the absolute legal right
, to consent to SUD treatment at any age without parental knowledge or consent (MCL
330.1264). Conversely, outpatient mental health treatment without parental consent
requires the minor to be at least 14 years old and is strictly capped at 12 sessions or 4
months (MCL 330.1707).
● The 2026 HIPAA/Part 2 Alignment: Under the finalized federal updates, patients can
sign a single consent form for all future Treatment, Payment, and Healthcare Operations
(TPO), and clinical programs are no longer required to strictly segregate SUD records
from general medical records.
● MDHHS-5515 Standardization: Public Act 129 of 2014 mandates that all providers must
accept the MDHHS-5515 Standard Consent Form for sharing behavioral health and SUD
information. It cannot be rejected for local proprietary forms.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: Under the updated ASAM Criteria 4th Edition, an adult patient undergoing intake reports a
history of severe opioid use disorder, current active cravings, and severe anxiety regarding
potential withdrawal. The clinician must formally evaluate the clinical indication for
buprenorphine. Under which specific assessment dimension must this pharmacological
evaluation be documented? A) Dimension 2: Biomedical Conditions B) Dimension 1:
Intoxication, Withdrawal, and Addiction Medications C) Dimension 4: Substance Use-Related
Risks D) Dimension 6: Person-Centered Considerations
● The Answer: B (Dimension 1: Intoxication, Withdrawal, and Addiction Medications)
● Distractor Analysis:
○ A is incorrect: Dimension 2 assesses physical health complications, chronic
physical pain, or pregnancy-related concerns, not the direct pharmacological
management of substance cravings or acute withdrawal.
○ C is incorrect: Dimension 4 evaluates the imminent behavioral risk of continued use
and the behavioral harms associated with it, not the biological indication for
pharmacotherapy.
○ D is incorrect: Dimension 6 assesses patient preferences, barriers to care, and
Social Determinants of Health (SDOH). While a patient may prefer MAT, the core
clinical evaluation of its necessity resides in Dimension 1.
The Mentor's Analysis: The 4th Edition explicitly appended Addiction Medications to
Dimension 1 to definitively align addiction treatment with mainstream medical practices, moving
away from outdated, abstinence-only biases. Originating from a systemic need to reduce opioid
overdose mortality, this mechanism forces the evaluator to consider neurobiological stabilization
immediately. By utilizing Dimension 1 for MAT evaluations, clinicians bypass the legacy trap of
treating pharmacotherapy as a secondary afterthought. Professional/Academic Intuition: If
the patient's brain is biologically craving or withdrawing, the clinical reflex MUST be to
assess Dimension 1 for immediate medical stabilization.
Q2: A 13-year-old middle school student presents independently to a Michigan outpatient clinic
requesting treatment specifically for Alcohol Use Disorder. The adolescent explicitly states they
will not participate if their parents are notified. Based strictly on Michigan Compiled Laws (MCL
330.1264), which action is the MOST ACCURATE regarding the adolescent's admission? A)
The clinic must reject admission until the minor turns 14, aligning with standard mental health
, minor consent laws. B) The clinic may admit the minor, but must inform the parents within 72
hours as mandated by standard duty of care protocols. C) The minor may consent to and
receive the SUD treatment, and parental consent or knowledge is legally unnecessary. D) The
minor may consent, but treatment is strictly limited to a maximum of 12 sessions or 4 months
before parental consent is triggered.
● The Answer: C (The minor may consent to and receive the SUD treatment, and parental
consent or knowledge is legally unnecessary.)
● Distractor Analysis:
○ A is incorrect: While outpatient mental health care requires a minor to be at least 14
years old (MCL 330.1707), SUD treatment under MCL 330.1264 has no minimum
age restriction.
○ B is incorrect: The law does not mandate a 72-hour notification; the minor's consent
is valid independently, and 42 CFR Part 2 strictly protects this confidentiality.
○ D is incorrect: This distractor maliciously conflates the mental health consent law
(MCL 330.1707), which has a 12-session/4-month limit, with the SUD consent law
(MCL 330.1264), which permits unlimited sessions to address the chronic nature of
addiction.
The Mentor's Analysis: Michigan legislates a critical, life-saving distinction between general
mental health care and substance use disorder treatment for minors. Because addiction
presents an immediate, lethal physiological threat, the state intentionally removes all parental
barriers to entry, recognizing that parental notification often deters vulnerable youth from
seeking help. By utilizing MCL 330.1264, you bypass the common novice error of improperly
restricting SUD services based on broader mental health statutes. Professional/Academic
Intuition: In Michigan, minor SUD consent is unlimited in duration and age; minor mental
health consent is temporally and age-restricted. Never mix the two statutes.
Q3: The 2026 final rule aligning 42 CFR Part 2 with HIPAA introduces a monumental shift in
how patient consent is processed for Substance Use Disorder (SUD) records. When a patient
signs a consent form at intake under the new regulations, what is the MOST SIGNIFICANT
operational change regarding how the clinic manages that data? A) The clinic can now freely
publish patient outcomes on public health registries without any form of de-identification. B) The
patient signs a single consent form that broadly covers all future uses and disclosures for
Treatment, Payment, and Healthcare Operations (TPO). C) The clinic must now maintain
entirely physically segregated servers for SUD records separate from standard medical records.
D) The patient must sign a new, individual consent form for every single medical provider
involved in their external care continuum.
● The Answer: B (The patient signs a single consent form that broadly covers all future
uses and disclosures for Treatment, Payment, and Healthcare Operations (TPO).)
● Distractor Analysis:
○ A is incorrect: Public health disclosures must still be rigorously de-identified in
accordance with standard HIPAA guidelines.
○ C is incorrect: The update explicitly eliminates the highly burdensome and
dangerous requirement that Part 2 programs physically or digitally segregate SUD
records from general medical records.
○ D is incorrect: This describes the archaic, pre-2024 legacy rule. The new standard
permits a single, global consent for TPO, dramatically streamlining care
coordination and reducing administrative decay.
The Mentor's Analysis: The historical fragmentation of healthcare records literally cost lives,
as emergency departments could not quickly access life-saving SUD data without jumping
Test Bank & Study
Guide
PART 0: THE TABLE OF CONTENTS
Section Cognitive Tier Subject Focus Page/Section
Reference
PART I: THE System Initialization Critical Axioms & Exam Section 1.0
PREVIEW Architecture
PART II: THE ELITE Core Assessment Comprehensive Section 2.0
TEST BANK Gauntlet Subject Mastery
- Tier 1 (Questions Foundational Syntax & Definitions, MCBAP Section 2.1
1–10) Application Ethics, ASAM 4th Ed
Baseline
- Tier 2 (Questions Complex Application & MDHHS-5515, 42 CFR Section 2.2
11–20) Simulation Part 2 Updates, Minor
Consent
- Tier 3 (Questions Grandmaster Synthesis Duty to Warn vs Section 2.3
21–30) Federal Law,
Co-occurring Triage
PART I: THE PREVIEW
Mastering this clinical test bank translates directly to elite, unimpeachable clinical competence
within Michigan's highly regulated behavioral health infrastructure. By internalizing these
multidimensional scenarios, you will bypass novice pitfalls, ensuring your diagnostic
formulations and legal compliance meet the absolute highest standards of the Michigan
Certification Board for Addiction Professionals (MCBAP).
Critical Axioms (The Hard Deck):
● The Federal Supremacy Rule (42 CFR Part 2 vs. Duty to Warn): State-mandated Duty
to Warn (MCL 330.1946) NEVER supersedes federal SUD confidentiality (42 CFR Part 2).
You must secure a specific court order, make an anonymous report, or report without
identifying the patient as receiving SUD treatment.
● The ASAM 4th Edition Paradigm Shift: Dimension 1 now explicitly mandates the
evaluation of Addiction Medications, forcing clinicians to view Medication for Addiction
Treatment (MAT) as a frontline biological intervention. Dimension 6 Person-Centered
Considerations now absorbs readiness to change while addressing Social Determinants
of Health (SDOH).
● Michigan Minor Consent Laws: A minor in Michigan possesses the absolute legal right
, to consent to SUD treatment at any age without parental knowledge or consent (MCL
330.1264). Conversely, outpatient mental health treatment without parental consent
requires the minor to be at least 14 years old and is strictly capped at 12 sessions or 4
months (MCL 330.1707).
● The 2026 HIPAA/Part 2 Alignment: Under the finalized federal updates, patients can
sign a single consent form for all future Treatment, Payment, and Healthcare Operations
(TPO), and clinical programs are no longer required to strictly segregate SUD records
from general medical records.
● MDHHS-5515 Standardization: Public Act 129 of 2014 mandates that all providers must
accept the MDHHS-5515 Standard Consent Form for sharing behavioral health and SUD
information. It cannot be rejected for local proprietary forms.
PART II: THE ELITE TEST BANK
Tier 1: Foundational Syntax & Application
Q1: Under the updated ASAM Criteria 4th Edition, an adult patient undergoing intake reports a
history of severe opioid use disorder, current active cravings, and severe anxiety regarding
potential withdrawal. The clinician must formally evaluate the clinical indication for
buprenorphine. Under which specific assessment dimension must this pharmacological
evaluation be documented? A) Dimension 2: Biomedical Conditions B) Dimension 1:
Intoxication, Withdrawal, and Addiction Medications C) Dimension 4: Substance Use-Related
Risks D) Dimension 6: Person-Centered Considerations
● The Answer: B (Dimension 1: Intoxication, Withdrawal, and Addiction Medications)
● Distractor Analysis:
○ A is incorrect: Dimension 2 assesses physical health complications, chronic
physical pain, or pregnancy-related concerns, not the direct pharmacological
management of substance cravings or acute withdrawal.
○ C is incorrect: Dimension 4 evaluates the imminent behavioral risk of continued use
and the behavioral harms associated with it, not the biological indication for
pharmacotherapy.
○ D is incorrect: Dimension 6 assesses patient preferences, barriers to care, and
Social Determinants of Health (SDOH). While a patient may prefer MAT, the core
clinical evaluation of its necessity resides in Dimension 1.
The Mentor's Analysis: The 4th Edition explicitly appended Addiction Medications to
Dimension 1 to definitively align addiction treatment with mainstream medical practices, moving
away from outdated, abstinence-only biases. Originating from a systemic need to reduce opioid
overdose mortality, this mechanism forces the evaluator to consider neurobiological stabilization
immediately. By utilizing Dimension 1 for MAT evaluations, clinicians bypass the legacy trap of
treating pharmacotherapy as a secondary afterthought. Professional/Academic Intuition: If
the patient's brain is biologically craving or withdrawing, the clinical reflex MUST be to
assess Dimension 1 for immediate medical stabilization.
Q2: A 13-year-old middle school student presents independently to a Michigan outpatient clinic
requesting treatment specifically for Alcohol Use Disorder. The adolescent explicitly states they
will not participate if their parents are notified. Based strictly on Michigan Compiled Laws (MCL
330.1264), which action is the MOST ACCURATE regarding the adolescent's admission? A)
The clinic must reject admission until the minor turns 14, aligning with standard mental health
, minor consent laws. B) The clinic may admit the minor, but must inform the parents within 72
hours as mandated by standard duty of care protocols. C) The minor may consent to and
receive the SUD treatment, and parental consent or knowledge is legally unnecessary. D) The
minor may consent, but treatment is strictly limited to a maximum of 12 sessions or 4 months
before parental consent is triggered.
● The Answer: C (The minor may consent to and receive the SUD treatment, and parental
consent or knowledge is legally unnecessary.)
● Distractor Analysis:
○ A is incorrect: While outpatient mental health care requires a minor to be at least 14
years old (MCL 330.1707), SUD treatment under MCL 330.1264 has no minimum
age restriction.
○ B is incorrect: The law does not mandate a 72-hour notification; the minor's consent
is valid independently, and 42 CFR Part 2 strictly protects this confidentiality.
○ D is incorrect: This distractor maliciously conflates the mental health consent law
(MCL 330.1707), which has a 12-session/4-month limit, with the SUD consent law
(MCL 330.1264), which permits unlimited sessions to address the chronic nature of
addiction.
The Mentor's Analysis: Michigan legislates a critical, life-saving distinction between general
mental health care and substance use disorder treatment for minors. Because addiction
presents an immediate, lethal physiological threat, the state intentionally removes all parental
barriers to entry, recognizing that parental notification often deters vulnerable youth from
seeking help. By utilizing MCL 330.1264, you bypass the common novice error of improperly
restricting SUD services based on broader mental health statutes. Professional/Academic
Intuition: In Michigan, minor SUD consent is unlimited in duration and age; minor mental
health consent is temporally and age-restricted. Never mix the two statutes.
Q3: The 2026 final rule aligning 42 CFR Part 2 with HIPAA introduces a monumental shift in
how patient consent is processed for Substance Use Disorder (SUD) records. When a patient
signs a consent form at intake under the new regulations, what is the MOST SIGNIFICANT
operational change regarding how the clinic manages that data? A) The clinic can now freely
publish patient outcomes on public health registries without any form of de-identification. B) The
patient signs a single consent form that broadly covers all future uses and disclosures for
Treatment, Payment, and Healthcare Operations (TPO). C) The clinic must now maintain
entirely physically segregated servers for SUD records separate from standard medical records.
D) The patient must sign a new, individual consent form for every single medical provider
involved in their external care continuum.
● The Answer: B (The patient signs a single consent form that broadly covers all future
uses and disclosures for Treatment, Payment, and Healthcare Operations (TPO).)
● Distractor Analysis:
○ A is incorrect: Public health disclosures must still be rigorously de-identified in
accordance with standard HIPAA guidelines.
○ C is incorrect: The update explicitly eliminates the highly burdensome and
dangerous requirement that Part 2 programs physically or digitally segregate SUD
records from general medical records.
○ D is incorrect: This describes the archaic, pre-2024 legacy rule. The new standard
permits a single, global consent for TPO, dramatically streamlining care
coordination and reducing administrative decay.
The Mentor's Analysis: The historical fragmentation of healthcare records literally cost lives,
as emergency departments could not quickly access life-saving SUD data without jumping
